baber/WOPTO huggingface dataset:
Patent PT-722290-E (PT)
Inventor: ACKER DAVID ELLIS
IPC: A61M25/01
Filed: 1994-10-06
Abstract: A magnetic position and orientation determining system uses magnetic fields, desirably comprising uniform fields from Helmholtz coils (34, 36, 38) positioned on opposite sides of a sensing volume and gradient fields generated by the same coils. By monitoring field components detected at the probes (50) during application of these fields, the position and orientation of the probe (50) in the field can be deduced. A representation (108) of the probe (50) can be superposed on a separately acquired image of the subject to show the position and orientation of the probe (50) with respect to the subject.
Patent PT-673934-E (PT)
Inventor: HOUSSIN RAYMOND
IPC: A61P25/24
Filed: 1995-03-21
Abstract: Aminoalkyl benzothiazolinones of formula (I), their optical isomers, and their acid and base addn. salts, are new. R1 = H or opt. substd. alkyl; R2 = -(CH2)3-N(R3)R4 (gp.R21), or a gp. of formula (R22); R3, R4 = H, alkyl, cycloalkyl, cycloalkylalkyl, alkenyl, alkynyl or -(CH2)m-aryl (opt. substd. on aryl by one or more halo, hydroxy, alkyl (opt. substd. by one or more halo) or lower alkoxy); m = 0-4; or NR3R4 = a 5-9 atom heterocyclic gp., opt. contg. further heteroatoms (O or S) (opt. substd. by one or more alkyl), or form a 4-(methoxyphenyl)-piperazin-1-yl gp.; n = 2-4; R5, R6 = H or halo; alkyl and alkoxy are 1-6C; alkenyl and alkynyl are 2-6C; aryl = phenyl or naphthyl; cycloalkyl is 3-8C.
Patent PT-792329-E (PT)
Inventor: EDINGER SABINE
IPC: C09D163/00
Filed: 1995-11-15
Abstract: PCT No. PCT/EP95/04496 Sec. 371 Date May 14, 1997 Sec. 102(e) Date May 14, 1997 PCT Filed Nov. 15, 1995 PCT Pub. No. WO96/15203 PCT Pub. Date May 23, 1996The invention discloses a planar structure composed of at least one carrier layer (I) and at least one transparent cover coat (II); an optional back coat (III) arranged under the carrier coat (I) and made of a chemically or mechanically foamed expanded layer; and an optional compact or priming coat (IV) arranged between carrier layer (I) and cover coat (II) and/or between carrier layer (I) and back coat (III), wherein the coating compounds for the layers (II), (III), (IV) can be manufactured from a combination of: a) epoxidized products of esters of unsaturated fatty acids having a chain length of C8 to C22 with multi valent aliphatic alcohols containing 2 through 6 carbon atoms; and which contain more than one epoxy group per molecule on average; and b) sub-esters of polycarboxylic acids with polyetherpolyols that contain at least one free carboxylic acid group per molecule and a double bond; c) optionally, a hydrophobing agent; and d) optionally, further additives from the group consisting of fillers, pigments, expanders and, auxiliary substances; whereinby the constituents, (a) and (b) are employed in a weight ratio of 0.6:1 to 1:1.4.
Patent PT-820428-E (PT)
Inventor: SALTIEL ALAN ROBERT
IPC: C07C47/277
Filed: 1996-02-05
Abstract: Dialkyl ethers lower Lp(a) and triglycerides, and elevate HDL-cholesterol, and are thereby useful for treating vascular diseases and noninsulin-dependent diabetes mellitus.
Patent PT-984762-E (PT)
Inventor: ROTH NATHAN
IPC: A61K9/00
Filed: 1998-05-07
Abstract: The present invention is directed to an oral active agent delivery system comprising improved flow controllers. A hollow tubular member (10) containing the active agent formulation and having a fluid passing controller (14) is placed at one end (16) into a fluid and at a second end (18) into a patient's mouth. The active agent is delivered when the patient sips on the end of the chamber. The improved controllers prevent leakage of the active agent formulation.
Patent PT-1071410-E (PT)
Inventor: TILLET YVES THEODORE
IPC: A61K9/00
Filed: 1999-04-13
Abstract: A composition for relieving a sensation of respiratory discomfort and/or for promoting natural regeneration of mucous membranes of the nasal cavity. The composition contains levomenthol at a concentration between 10 and 250 mg/l, dissolved in an aqueous ionic solution having an osmolarity at least equal to that of an aqueous solution of sodium chloride at 9 g/l. The aqueous ionic solution is pure sea water, diluted sea water, an aqueous sodium chloride solution, an aqueous sodium chloride solution further containing at least one salt found in sea water, or a mixture thereof.
Patent PT-1208304-E (PT)
Inventor: STARK JOHN HERMAN
IPC: C02F1/44
Filed: 1999-08-31
Abstract: The lifetime of a double-cone device (21) for creating a pressure difference in a streaming fluid can be greatly increased by moving the inlet gap (5) into the exit cone (4). This results in a short so-called diffuser (22) being obtained between the gap (5) and the orifice (19), where entry cone (3) and exit cone (4) are connected. The increased lifetime permits the double-cone device to cope with much higher flow rates. Thus higher system pressures are created which enhance the use of the double-cone for such applications as the desalination of sea water by reverse osmosis.The important application of the seperation of oil from water using a separating device such as a cyclone (57) working under elevated pressure is now feasible.The increased power of the double-cone permits one to profit more fully from the new concept of reduction of the concentration of the feed supplied to the double-cone device (21).
Patent SG-88388-G (SG)
Title: 2-(fluoroalkylthio)substituted penems,processes for preparing them,and pharmaceutical compositions containing them
IPC: C07D499/00
Filed: 1988-12-24
Abstract: Disclosed herein are (5R,6S,8R)-6-(1-hydroxyethyl)-2-(2-fluoroethylthio)-penem-3-carboxylic acid and the metabolisable esters thereof and alkali metal salts thereof, which are potent antibacterial agents.
Patent IE-850289-L (IE)
Title: Immunization of mammals using avian and/or bovid antibody
IPC: A61P31/04
Filed: 1985-02-06
Abstract: A method of passively immunizing a mammal against a condition caused by an antigen comprising: administering to the mammal immunizing amounts of an antibody obtained from a domesticated fowl or bovid which has been immunized against the antigen: the mammal being tolerant to the antibody by virtue of having a history of consumption of antibody containing material derived from the egg of a fowl or milk of a bovid.
Patent IE-34111-L (IE)
Title: 2-chloro- d1,4-steroids
IPC: B65D39/00
Filed: 1970-04-21
Abstract: Novel 2-chloro- DELTA 1,4-steroids having the formula WHEREIN R1 is hydrogen or methyl, R2 is hydrogen, hydroxyl or esterified hydroxyl, X is fluorine, chlorine or methyl, Y is hydrogen or halogen, and Z is halogen having the same or a smaller atomic weight then Y, a beta -position hydroxyl and in the case where Y is hydrogen, an alpha -position hydroxyl.
[US3678034A]
Patent IE-790676-L (IE)
Title: N-heterocyclyl-4-piperidinamines
IPC: C07D265/36
Filed: 1979-08-08
Abstract: Novel N-heterocyclyl-4-piperidinamines wherein said heterocyclic radical is an optionally substituted 1H-benz-imidazol-2-yl or 3H-imidazo[4,5-b]pyridin-2-yl radical, said compounds being useful as antihistaminic agents.
[EP0005318A1]
Patent IE-40951-L (IE)
Title: Preparation of 1, 4- diazepines.
IPC: C07D405/10
Filed: 1975-03-27
Abstract: Novel 5-amino-7-phenyl-2,3-dihydro-1H-1,4-diazepines of the formula I are prepared. <IMAGE> R1, R2 and R3 are, independently of one another, hydrogen, an alkyl group with 1-4 carbon atoms, an alkoxy group with 1-4 carbon atoms, fluorine, chlorine or bromine, or two of the substituents R1, R2 and R3, which are located on adjacent carbon atoms, represent a methylenedioxy group. The compounds of the formula Ia <IMAGE> in which R1 is t-butyl are heated in the presence of free acid for this purpose. The compounds are active against obesity and have an antidiabetic effect. 5-Amino-7-phenyl-2,3-dihydro-1H-1,4-diazepine is preferred.
[GB1494433A]
Patent IE-34685-L (IE)
Title: Displaying a physical event
IPC: G01V1/28
Filed: 1970-06-18
Abstract: Seismographic signals are separated by filters into their low-, medium-, and high-frequency component signals and the envelope of each is generated and displayed in a different color, e.g., red, green, and blue, respectively. The displays are superimposed, and combined with the seismic trace so as to show both frequency content and time varying amplitude simultaneously.
[US3781785A]
Patent IE-41362-L (IE)
Title: Sewing machine
IPC: G07C3/04
Filed: 1975-05-07
Abstract: 1513239 Revolution counters J MILOM 14 May 1975 [27 Sept 1974] 42178/74 Heading G1N The number of revolutions of the output shaft 1, Fig. 1, of a sewing machine is measured by counting the pulses produced in a pick-up head 7 by a ferrous plate 6 attached to the rotating shaft 1, the pick-up head comprising a bar magnet 11, Fig. 5, surrounded by a coil 12.
[GB1513239A]
Patent IE-781056-L (IE)
Title: Cephalosporin derivatives.
IPC: C07D279/08
Filed: 1978-05-26
Abstract: 1. Cephalosporin derivatives of the general formula see diagramm : EP0000005,P15,F1 wherein R represents furyl, thienyl or phenyl optionally substituted by halogen, hydroxy, lower alkoxy or lower alkyl, R1 represents lower alkyl or aminocarbonylmethyl and X represents a group of the formulae see diagramm : EP0000005,P15,F2 see diagramm : EP0000005,P15,F3 see diagramm : EP0000005,P15,F4 in which one of the two symbols R2 and R3 or R4 and R5 represents hydrogen and the other represents lower alkyl, carboxymethyl or sulphomethyl, as well as salts of said compounds and hydrates of said salts.
[EP0000005A1]
Patent IE-851331-L (IE)
Title: Insulin precursors
IPC: C12N15/17
Filed: 1985-05-29
Abstract: Human insulin precursors containing the peptide chain B(1-29)-A(1-21) of human insulin and derivatives thereof with a bridging chain connecting the carboxyl terminus of the B(1-29)- chain with the amino terminus of the A(1-21 )-chain are prepared by culturing a yeast host transformed with a replicable expression vehicle capable of expressing a DNA- sequence encoding the insulin precursor. The bridging chain is preferably relatively short and contains preferably from 2 to 8 amino acid residues. The bridging chain must not contain two adjacent basic amino acid residues (Lys or Arg) and has one Lys or Arg connected to the amino terminus of the (A(1-21)- chain. Human insulin is prepared from the insulin precursors by in vitro conversion.
Patent IE-32582-L (IE)
Title: Blood sampling tubes.
IPC: A61B5/154
Filed: 1968-12-05
Abstract: Blood sampling apparatus comprises a tube holder 14 and an evacuated sampling tube 12 having an open end closed by a stopper, the stopper having a thin imperforate diaphragm 28, puncturable by an inner end of a needle 18 secured in holder 14 the diaphragm defining the lower end of a hole 16 at least part of which has a diameter less than that of needle 18 for sealing against the latter. The stopper may have a periphral flange sealing against the edge of the open end of tube 12. The outer end of hole 16 is enlarged at 26 and the outer face of the stopper may be generally concave or convex or flat.
[GB1256521A]
Patent IE-34762-L (IE)
Title: Cephalosporins
IPC: A23K20/195
Filed: 1970-11-25
Abstract: 1336318 Cephalosporins CIBA-GEIGY AG 27 Nov 1970 [28 Nov 1969 24 Dec 1969 17 Feb 1970 20 April 1970 2 June 1970] 56413/70 Heading C2A Novel cephalosporins having the Formula (I): and salts and esters thereof, wherein R 1 and R 2 are each hydrogen, an optionally substituted hydrocarbon radical or an optionally substituted heterocyclyl radical attached by a ring carbon atom, or R 1 and R 2 together represent a divalent hydrocarbon radical which may be interrupted by one or more hetero atoms and/ or substituted, and R 3 is a heterocyclyl radical of aromatic character which is attached by a ring carbon atom and contains at least two nitrogens and a further N, S or O atom, and which may be substituted by C 1 -C 5 alkyl, C 1 -C 5 alkylthio, cycloalkyl, thienyl or phenyl, the latter being optionally substituted by halogen, nitro, C 1 -C 5 alkyl or C 1 -C 5 alkoxy, are prepared (a) by reacting a compound of Formula (II): in which R<SP>1</SP> 3 is an esterified hydroxy group and R 4 is an acyl radical of Formula (Ia): wherein R 1 and R 2 are as above, with a thiol of formula (Ib): HS-R 3 or a metal salt thereof; or (b) by acylating a compound of Formula II wherein R 4 is H and R<SP>1</SP> 3 is -S-R 3 with an acylating agent providing an acyl group of Formula Ia. The products of (a) or (b) may, when R 1 and R 2 are each hydrogen, be further reacted with an aldehyde, a ketone or a nitrile, preferably in the presence of a catalyst (such as an acetate of ammonia or an amine, p-aminophenol or a salt of the compound (II) with ammonia or an amine) to give a compound of Formula (I) in which R<SP>1</SP> and R<SP>2</SP> together form an optionally substituted alkylidene or cycloalkylidene group. Pharmaceutical compositions having broad spectrum antibacterial activity comprise a compound of Formula (I) above or a salt or ester thereof and a pharmaceutical diluent, excipient or carrier.
[GB1336318A]
Patent IE-781519-L (IE)
Title: 1-phenylethanolamine derivatives
IPC: C07C239/00
Filed: 1978-07-27
Abstract: The invention relates to topically anti-inflammatory 1-phenylethanolamine derivatives of the general formula I:- or acid-addition salts thereof, to pharmaceutical compositions thereof, and to analogy processes for their manufacture. A representative compound is 1-(4-amino -3,5- dichlorophenyl) -2- [1,1-dimethyl -2- (2-phenylacetamido) ethylamino] ethanol. The derivatives are useful in particular for the treatment of inflammatory diseases or conditions of the skin.[EP0000809A1]
Patent IE-43410-L (IE)
Title: Vaginal suppository
IPC: A61K9/02
Filed: 1976-07-29
Abstract: A spermicidally-active vaginal suppository consisting essentially of a solid water-soluble polymeric material which melts at body temperature, for example, a polyethylene glycol, having dispersed therein minor amounts of a spermicide, for example, p-nonylphenoxypolyethoxyethanol, a foaming agent operative when the suppository is dissolved in aqueous media to generate a foam-forming gas, for example, a mixture of a water-soluble bicarbonate and a solid weak acid, and a foam-stabilizing agent which is characterized by containing a surfactant, which is effective to reduce the surface tension of water to less than 45 dynes per centimeter, for example, sodium lauryl sulfate, and lactalbumin.
[US4323548A]
Patent IE-781945-L (IE)
Title: Metallised textile fabric.
IPC: C23C18/30
Filed: 1978-09-28
Abstract: The invention relates to a metallized textile material having a surface resistance as measured at 23 DEG C./50% relative humidity in accordance with DIN 54 345 of at most 1x103 ohm. The invention also relates to a process for the production of such metallized textile material by currentless metal deposition, preferably at room temperature, thereon wherein the activation of the material is effected in a colloidal palladium solution, preferably at room temperature.
[US4201825A]
Patent IE-38514-L (IE)
Title: Insulin preparations.
IPC: C07K16/00
Filed: 1973-11-15
Abstract: 1450598 Insulin preparations HOECHST AG 14 Nov 1973 [16 Nov 1972] 52889/73 Heading A5B Insulin preparations useful as depot insulin for the treatment of diabetes mellitus comprise, in an aqueous suspension, a crystallised complete insulin and amorphous desphenyl-alanine B1 insulin of the same species. The two insulin components are porcine or bovine and the preparation preferably has a pH of 6.8 to 7.6. The preparations may also contain zinc ions (e.g. from zinc chloride), sodium acetate, sodium chloride, and/or a preservative such as 4-hydroxybenzoic acid methyl ester. The preparations are administered parenterally and may be in dosage unit form e.g. an ampoule or in a two-coponent pack.
[GB1450598A]
Patent IE-802485-L (IE)
Title: Infectious-bronchitis vaccines
IPC: A61K39/295
Filed: 1980-11-28
Abstract: Infectious bronchitis (IB) vaccines for poultry derived from at least one novel virus strain of novel infectious bronchitis serotypes, selected from the group consisting of culture Nos. CNCTC A 07/80, CNCTC A 08/80, CNCTC A 09/80, CNCTC A 010/80, CNCTC A 011/80, CNCTC A 013/80, CNCTC A 014/80, CNCTC A 015/80 and CNCTC A 016/80 deposited at the Czechoslovak National Collection of Type Cultures of the Institute of Hygiene and Epidemiology in Prague, Czechoslovakia and the novel viruses per se, combined virus vaccaines and a novel method of protecting poultry from infectious bronchitis.
[US4505892A]
Patent NO-853786-L (NO)
Inventor: ALBIZZATI ENRICO
IPC: C08F10/00
Filed: 1985-09-26
Abstract: Supported components (component (c)) and the corresponding catalysts for polymerizing olefins, comprising the product of the reaction among :  (a) a metallorganic Al compound; (b) an electron-donor compound reactive towards MgCl2 but not capable of forming complexes with AlEt3 in standard conditions; (c) a solid including a halogenated tetravalent titanium compound and an electron-donor compound, supported on titanium trichloride or tribromide or on vanadium trichloride or tribromide having a surface area of at least 100m<2>/g, the electron-donor compound being characterized in that it is extractable with AlEt3 (under standard conditions) for at least 70% by moles.
Patent NO-872995-L (NO)
Inventor: HOSHI KAZUO
IPC: C08F255/00
Filed: 1987-07-17
Abstract: A flame-retardant olefinic resin composition comprising   (A) l00 parts by weight of a mixed resin consisting of an olefinic resin and a silane-grafted polymer obtained by grafting a silane to said olefinic resin,   (B) 50 to 300 parts by weight of a hydrated metal compound, and (C) 0.l to 30 parts by weight of a dicarboxylic acid or dicarboxylic acid anhydride derivative. c
Patent NO-891187-L (NO)
Inventor: NIEDBALLA ULRICH
IPC: A61P35/00
Filed: 1989-03-17
Abstract: Porphyrin complex compounds, consisting of a meso-tetraphenyl- porphyrin ligand, if appropriate at least one ion of an element of atomic number 13, 21, 32, 37-39, 42-44, 49, 50 or 57-83 and, if appropriate, cations of inorganic and/or organic bases, amino acids or amino acid amides, are useful diagnostics and therapeutics.
Patent NO-902528-L (NO)
Inventor: GUERRY PHILIPPE
IPC: C07C225/10
Filed: 1990-06-07
Abstract: The compounds of the general formula 
<IMAGE>
 in which R<1> and R<2> each denote hydrogen, lower alkyl or lower alkenyl or together denote straight-chain alkylene having 2 to 4 carbon atoms, R<3> denotes hydrogen, halogen or lower alkyl, Q denotes alkylene having 2 to 11 carbon atoms and at least 2 carbon atoms between the two free valencies or alkenylene having 4 to 11 carbon atoms and at least 4 carbon atoms between the two free valencies and Y and Y' each denote a direct bond or the group -CH2-, -CH2CH2-, -CH=CH- or -C IDENTICAL C-, the group R<1>R<2>N-Q-CH2- is bonded to the 3- or 4-position of the ring designated A, and the symbol R denotes that the ring is unsubstituted or substituted by halogen, trifluoromethyl, cyano, nitro, lower alkyl or lower alkoxy,
 and their pharmaceutically acceptable acid addition salts have useful pharmacological properties. In particular, they have a pronounced antifungal action and exhibit synergistic effects in combination with known antifungal substances which inhibit sterol biosynthesis, such as ketoconazole and terbinafine. The compounds of the formula I can therefore be used as medicaments, in particular for the control or prevention of topical or systemic infections which are caused by pathogenic fungi.
Patent NO-904721-L (NO)
Title: Brenner-munnstykke.
Inventor: YOUNG TIMOTHY M
IPC: E21B41/00
Filed: 1990-10-31
Abstract: Et brennermunnstykke (10) for brenning av petroleums-produkter. Brennermunnstykket (10) Innbefatter et rarparti (12) med en brennermunnstykke-innsats (22). En mutter (48) er i gjengeinngrep med rarpartiet (12) for å holde Innsatsen (22) på plass. Innsatsen (22) har et hovedsakelig konisk munnstykkeparti (24) med et innlapsparti (32) som forlaper hovedsakelig vinkelrett til munnstykkepartiets (24) lengdeakse. Innlapspartiet (32) definerer et antall innlepsporter (38). Innleps-portene (38) er skråstilt med hensyn til lengdeaksen og har en utlapsende nær inntil en indre flate (34) av munnstykkepartiet (24).
Patent NO-905270-L (NO)
Inventor: OSBORNE JAMES L
IPC: A61M37/00
Filed: 1990-12-06
Abstract: Subsaturated, rate controlled delivery devices (1) for delivering an agent (5). The initial equilibrated concentration of the agent in the agent reservoir (3) and the adhesive (5) is below saturation. The initial loading of the agent in reservoir (3) is sufficient to prevent the activity of the agent in the reservoir (3) from decreasing by more than about 75 % and preferably no more than about 25 % during the predetermined period of administration. The thicknesses of the adhesive (5), rate controlling membrane (4) and reservoir (3) layers are selected so that at least 50 % and, preferably at least 75 % of the initial equilibrated agent loading is in the reservoir layer (3). The devices (1) are usable to deliver agents which are liquid at body temperatures such as benzotropine, secoverine, nicotine, arecoline, polyethylene glycol monolaurate, glycerol monolaurate, glycerol monooleate and ethanol, for example.
Patent NO-913280-L (NO)
Inventor: LOFTON ELIZABETH PAUL
IPC: D06M13/12
Filed: 1991-08-22
Abstract: A method for treating a flexible, porous substrate, such as a non-woven fabric, with a water-borne formaldehyde-free composition comprising an emulsion-polymerized binder containing copolymerized ethylenically-unsaturated dicarboxylic acids, or derivatives thereof, wherein the binder is partially neutralized with a fixed base.
Patent NO-921654-L (NO)
Inventor: HRIB NICHOLAS J
IPC: A61K31/428
Filed: 1992-04-28
Abstract: The present invention relates to benzisothiazole- and benzisoxazole-3-carboxamides of the formula I <CHEM> wherein R<1> is hydrogen or loweralkyl; R<2> is loweralkyl, or a group of the formula <CHEM> R<3> is hydrogen or loweralkyl; A is loweralkylene, a group of the formula -CHR<4>CH=CHCHR<4>-, or -CHR<4>C IDENTICAL CHR<4>-; R<4> is hydrogen or loweralkyl; X is O or S; W is N or CH; Y is hydrogen, loweralkyl, loweralkoxy, hydroxy, halogen, or trifluoromethyl; Z is hydrogen, loweralkyl, loweralkoxy, hydroxy, halogen, or trifluoromethyl; n is 1 or 2; wherein the solid line (-) refers to the point of attachment of the group to the indicated member of the formula; the geometric and optical isomers thereof; or a pharmaceutically acceptable salt thereof, useful for the treatment of psychoses, alone or in combination with inert adjuvants.
Patent NO-924884-L (NO)
Title: Fremgangsmaate for oppnaaelse av en representasjon som er tilpasset korrelasjonen av mono-dimensjonale opptegninger
Inventor: LARSONNEUR JEAN-LUC
IPC: G01V1/36
Filed: 1992-12-17
Abstract: Representasjon som muliggjør en enkel optisk korrelasjon av to signaler, idet representasjonen er kjennetegnet ved at etter selektering av en elementær familie av småbølger, blir modulus, fase, reell eller imaginær del av transformasjonene representert i form av små bølger for det første signal og av transformasjonen i små bølger for det andre signal, samtidig som begge transformasjoner blir omdannet side om side.
Patent NO-940394-L (NO)
Inventor: CARLO LOUIS D
IPC: B60R25/10
Filed: 1994-02-07
Abstract: An anti-theft device for a motor vehicle wherein a personal identification unit (T) is carried by an authorized operator of said motor vehicle and includes means for identifying its location in the vicinity of the motor vehicle. A vehicle control unit (10) mounted onto the motor vehicle, has a first and second condition with means for allowing operation of the motor vehicle when the control unit is in the first condition and means for inhibiting operation of the motor vehicle when said control unit is in the second condition and means for shifting the control unit into the second condition at a time subsequent to removal of the identification device (T) from the vicinity of the motor vehicle. <IMAGE>